Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesPhase I Clinical Studies of the Advanced Glycation End-product (AGE)-Breaker TRC4186: Safety, Tolerability and Pharmacokinetics in Healthy Subjects
Clinical Drug Investigation, 08/13/09
Chandra KP et al. – TRC4186 was safe and well tolerated when administered orally with either a single or multiple doses across the different ages, sexes, races and formulations studied. A dose–proportional increase in plasma TRC4186 concentration was seen, with steady state being achieved within 6 days.
Today in Pharmacokinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
U-500 Regular Insulin: Clinical Experience and Pharmacokinetics in Obese, Severely Insulin Resistant Type 2 Diabetic Patients
Diabetes Care, 11/16/09
The role of ceramide in major depressive disorder
European Archives of Psychiatry and Clinical Neuroscience, 11/12/09
Randomized Trial and Pharmacokinetic Study of Pegfilgrastim versus Filgrastim after Dose-Intensive Chemotherapy in Young Adults and Children with Sarcomas
Clinical Cancer Research, 11/20/09
Sponsor
Article Search
Sponsor